REVIR
Live / Registered — Registered (as of 24 Jan 2023)
What this means for you
Registered since 24 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97196705
- Registration number
- 6963609
- Mark type
- Stylized text
- Filed
- 30 Dec 2021
- Published for opposition
- 08 Nov 2022
- Registered
- 24 Jan 2023
- Attorney of record
- Enshan Hong
Goods and services
- Class 042 — Scientific and technological services: Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission
Owner
- Revir Therapeutics, Inc., Foster City, CA, US
- Revir Therapeutics, Inc., Foster City, CA, US
- Revir Therapeutics, Inc., Foster City, CA, US
Prosecution history
- 24 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Nov 2022 — PUBLISHED FOR OPPOSITION
- 19 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Oct 2022 — EXAMINER'S AMENDMENT ENTERED
- 05 Oct 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Oct 2022 — EXAMINERS AMENDMENT E-MAILED
- 05 Oct 2022 — EXAMINERS AMENDMENT -WRITTEN
- 04 Oct 2022 — ASSIGNED TO EXAMINER
- 01 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Sept 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED